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Purpose: The purpose of this study was to determine whether transient hypoxia had an effect on transforming growth factor
β1 (TGFβ1)-induced rabbit corneal keratocyte myofibroblast transformation.
Methods: Primary isolated rabbit corneal keratocytes were cultured in a serum-free medium. The effect of transient
hypoxia treatment (1% oxygen, 4 h/day) on TGFβ1 (5 ng/ml)-induced α-smooth muscle actin (α-SM actin) expression
was examined by immunofluorescence, flow cytometry, and immunocytochemistry 72 h after treatment. We found that
hypoxia treatment significantly reduced the myofibroblast phenotype and α-SM actin expression that was induced by
TGFβ1. To explore the possible mechanism for this effect, we screened for the effects of hypoxia on several early
TGFβ-dependent signaling events including activated pSmad3, CREB (cAMP response element binding) binding protein
(CBP), MAPKs (Mitogen-activated protein kinase), and RhoA by co-immunoprecipitation and western blotting.
Results: Hypoxia alone increased α-SM actin expression and the association of pSmad3 to CBP, but it did not induce the
myofibroblast phenotype. The levels of pERK (the extracellular signal-regulated protein kinase) and pSmad3 or the extent
of the interaction between pSmad3 and CBP induced by TGFβ1 were not affected by hypoxia whereas the activation of
RhoA induced by TGFβ1 was significantly reduced.
Conclusions: We conclude that hypoxia can inhibit TGFβ1-induced corneal myofibroblast transformation and α-SM actin
expression. Our data show that this inhibition does not occur by altering Smads or MAPK signaling but possibly by
reducing the early activation of RhoA.
Wound  healing  is  a  complex  process  that  includes
apoptosis, cell activation and proliferation, differentiation,
and myofibroblast transformation. In many tissues, wound
healing is initially accompanied by ischemia/hypoxia due to
the disruption of the blood supply. Hypoxia can modulate
wound  healing  by  inhibiting  cytokine-induced  apoptosis
following wounding in cardiac myocytes [1], HepG2 (Human
hepatocellular liver carcinoma cell line) cells [2], and corneal
fibroblasts  [3].  Hypoxia  can  also  reduce  proliferation  of
human dermal fibroblasts [4] following wounding. However,
the  direct  effect  of  hypoxia  on  differentiation  to  the
myofibroblast phenotype has not been studied.
Transforming  growth  factor  β  (TGFβ)  is  the  major
mediator  responsible  for  myofibroblast  transformation.
Myofibroblasts  have  a  contractile  phenotype,  which  is
distinguished by the expression of α-smooth muscle actin (α-
SM actin), the assembly of stress fibers and focal adhesions,
and the altered extracellular matrix (ECM) production leading
to fibrotic wound healing in the heart [5], lung [6], and cornea
[7].  TGFβ  signaling  is  initiated  by  ligand  binding  to
transmembrane receptors I/II that induce phosphorylation of
Smad2/3, which combines with common Smad4, translocates
to  the  nucleus,  and  recruits  the  coactivator,  CBP  (CREB
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binding protein)/p300, to regulate downstream genes. TGFβ
also signals through the MAPK [8] or RhoA pathways [9]
either independently or as modulators of Smads.
Hypoxia increases fibronectin, collagen I, and collagen
IV protein expression in placental fibroblasts even though
TGFβ production was not increased by hypoxia, suggesting
that  ECM  production  can  be  stimulated  by  hypoxia
independent  of  TGFβ  [10].  On  the  other  hand,  hypoxia
increases TGFβ expression in HUVEC (Human Umbilical
Vein Endothelial cell line) cells, which suggests an interaction
of hypoxia on TGFβ bioactivity [11]. Hypoxia increases the
presence  of  the  transcriptional  factor,  HIF-1 α  ( Hypoxia
inducible  factor-1  alpha),  which  requires  the  coactivator,
CBP/p300. This might result in a possible competition for
CBP with Smads, thereby altering the TGFβ response. Indeed,
competitive  inhibition  has  been  observed  in  cardiac
fibroblasts where cAMP (cyclic Adenosine Monophosphate)-
elevating agents repress TGFβ signaling by activating CREB,
which  recruits  CBP1,  effectively  competing  with  Smad
transcriptional complexes [12]. These studies suggest that
hypoxia  could  modulate  TGFβ-induced  signaling  during
myofibroblast  transformation.  Whether  hypoxia  is  pro-
fibrotic or anti-fibrotic is probably dependent on the specific
cell type. In corneal stromal cells, the interaction between
hypoxia  and  TGFβ  and  the  effect  of  hypoxia  on  TGFβ-
induced myofibroblast transformation have not been studied.
In  a  previous  study,  we  showed  that  hypoxia  induced  a
significant increase of HIF1α after 4 h of hypoxia treatment
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1827in corneal stromal cells [3]. Given the potential interactions
between  HIF1α  and  Smad  signaling,  we  now  ask  if
intermittent  hypoxia  can  modulate  myofibroblast
differentiation  and  the  possible  involvement  of  Smads,
MAPK, and RhoA signaling pathways.
METHODS
Materials: The medium, additives, Alexa Fluor 488 goat anti-
mouse IgG, and collagenase were purchased from Invitrogen
(Cat: A-11001; Carlsbad, CA). TGFβ1 was obtained from
Biosource  (Camarillo,  CA).  Monoclonal  anti-α-SM  actin
antibody was obtained from Sigma Chemical Company (Cat:
2547;  St.  Louis,  MO).  Phospho-MAPK  family  antibodies
were purchased from Cell Signaling Technology (Danvers,
MA).
Cell culture and cell treatment: New Zealand White rabbit
eyes  were  delivered  from  Pel-Frez  (Rogers,  AR).  Rabbit
corneal keratocytes were cultured as previously described
[13]. Briefly, the epithelium was scraped off, the cornea was
dissected, and the endothelium was wiped off. The entire
stroma was put into DMEM (Dulbecco’s Modified Eagle’s
Medium) with 2 mg/ml collagenase, 0.5 mg/ml hyaluronidase,
and antibiotics at 37 °C overnight. The resultant isolated cells
were  washed  once  in  DMEM  and  seeded  in  serum-free
DMEM with non-essential amino acids, MEM vitamins, and
sodium pyruvate onto 12 mm glass coverslips double coated
with poly-lysine and collagen for immunocytochemistry and
onto 60 mm or 100 mm Petri dishes for immunochemistry,
pull down assays, and flow cytometry at 5×104 cells/cm2. For
immunochemistry, 5 ng/ml TGFβ1 was used to treat the cells
unless otherwise stated. For 4 h and 24 h treatments, drugs
were added once. For 72 h treatments, drugs were added every
day with medium change every other day.
Hypoxia treatment: For hypoxia treatment, cells were placed
in a hypoxia chamber (Coy Lab Products Inc., Grass Lake,
MI) equilibrated with 1% oxygen/5% CO2-balance nitrogen
and incubated for 4 h. For phenotypic experiments, cells were
treated with hypoxia (1% oxygen for 4 h every day) for three
days concurrent with or without TGFβ1. For evaluation of
pSmad3 and MAPK signaling, primary isolated rabbit corneal
keratocytes were treated with hypoxia (1% O2) for 4 h with or
without TGFβ1. Cells were immediately prepared for analysis
after treatment.
Immunocytochemistry: Cells were washed with fresh medium
and fixed in PBS containing 3% paraformaldehyde for 10 min
at room temperature. Fixed cells were then permeabilized with
acetone (−20 °C for 5 min). Coverslips were dried at room
temperature (RT), immediately rehydrated with PBS for 5
min, blocked in PBS:goat serum (1:1) for 1 h, incubated with
anti-α-SM actin (Sigma) at 1:100 in blocking medium for 1 h
at RT, and washed twice with PBS and then blocking medium
for 10 min. Cells were then incubated in goat anti-mouse IgG
Alexa  Fluor  488  at  1:20  for  40  min  (Molecular  Probes,
Eugene, OR), washed twice with PBS for 10 min, quickly
washed  with  dH2O,  and  mounted  in  Prolong  mounting
medium (Molecular Probes) with DAPI (4'-6-Diamidino-2-
phenylindole).
For western blots, cells were incubated with lysis buffer
(Pierce, Rockford, ILf) for 5 min, scraped, and centrifuged at
14,000× g for 10 min. The supernatants were collected and
stored at −80 °C. Protein concentrations were determined by
the  BCA  method.  Samples  were  separated  on  10%
polyacrylamide-SDS  gels  and  electroblotted  onto  PVDF
(Polyvinylidene Fluoride) membranes. After blocking with
PBST/5% skim milk, the membrane was incubated overnight
at 4 °C with primary antibodies against α-SM actin at 1:1,000
followed by peroxidase conjugated anti-mouse IgG at 1:1,000
for 1 h at room temperature. Signals were detected by ECL
(enhanced  luminol-based  chemiluminescent).  Each
experiment was repeated at least three times. For statistical
analysis,  band  density  was  analyzed  using  Un-scan-it  gel
analysis software (Silk Scientific, Orem, UT). The intensity
of the band of interest is divided by the intensity of the internal
control for all statistical analysis.
Flow cytometry: Rabbit corneal keratocytes (1.5×106) in 100
mm Petri dishes were detached with 0.25 mg/ml trypsin for 3
minutes, collected, and fixed in 2% paraformaldehyde for 5
min at RT, and permeabilized in 0.02% Triton with buffered
PBS.  Cells  were  then  blocked  with  1:1  PBS:filtered  goat
serum  for  1  h,  stained  with  mouse  anti-αSMA  antibody
(1:100) in blocking medium for 40 min at RT, washed twice
with PBS, and stained with goat anti-mouse IgG Alexa Fluor
488 (Invitrogen-Molecular Probes) at 1:20 for 40 min. Cells
were washed twice, and at least 5,000 cells per sample were
loaded in a FACSCalibur flow cytometer (Becton Dickinson,
San  Jose,  CA)  and  analyzed  by  CellQuest  software  (BD
biosciences  PharMingen,  San  Diego,  CA)  using  manual
gating according to intensity of fluorescence and cell size.
Co-immunoprecipitation:  Co-immunoprecipitation  (Co-IP)
was performed on nuclear extracts using the ExactaCruz C:
sc-45040 (Santa Cruz Biotechnology, Santa Cruz, CA) and
One-Step  IP-Western  Kit  (GenScript  Corporation,
Piscataway, NJ). Keratocytes (1.2×106) were plated onto 100
mm plates in serum free DMEM as stated above. Monoclonal
mouse anti-CBP from two companies were pooled together to
increase the binding efficiency. One hundred microliters of
the IP matrix with 15 μl of anti-CBP from Chemicon (Cat:
MAB1133; Temecula, CA) and 15 μl of anti-CBP from R&D
Systems (Cat: MAB2627; Minneapolis, MN) were incubated
by end-over-end rotation overnight at 4 °C to make the IP
antibody-IP  matrix  solution.  Cells  were  then  treated  with
forskolin  alone  or  together  with  TGFβ1  for  4  h.  Nuclear
extracts  were  collected  using  the  specified  lysis  buffer
together with proteinase and phosphatase inhibitors according
to  the  manufacturer’s  protocol  (Pierce).  The  lysate  was
incubated  with  the  IP  antibody-matrix  by  end-over-end
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from the pull-down were run on 10% polyacrylamide-SDS
gels and electroblotted onto nitrocellulose membranes (Bio-
Rad Laboratories, Hercules, CA). The membrane was cut in
half along the 100 kDa marker. The higher molecular weight
half was blotted with pooled anti-CBP antibody to check the
loading. The lower molecular weight half was blotted with
anti-pSmad3 (Cat: AB3226; R&D system) using GenScript
One-Step Western Blot detection.
RhoA  activity  assay:  RhoA  activity  was  measured  semi-
quantitatively  by  pull-down  assay  (Cat.  BK036;
Cytoskeleton, Denver, CO) according to the manufacturer’s
protocols. For pull-down assays, cells in 60 mm Petri dishes
were  lysed  in  550  μl  of  lysis  buffer  and  centrifuged  at
10,000× g for 2 min, and 450 μl of the supernatant was added
to 25 μg Rhotekin-RBD beads and incubated for 1 h at 4 °C.
Samples were washed once with washing buffer, boiled with
5× Laemmli sample buffer, run on 12% polyacrylamide-SDS
gels, electroblotted onto PVDF membranes, and detected with
1:2,000 mouse anti-RhoA antibody. Thirty-five microliters of
supernatant was used to detect total RhoA.
Myofibroblast cell counting: For keratocytes cultured on 12
mm coverslips, five random distinct 200× microscopic fields
were photographed on each coverslip. DAPI (+) cells were
counted to obtain the total cell count. DAPI (+) and α-SM actin
(+) cells were counted as myofibroblasts. Each experimental
condition  had  duplicate  or  triplicate  coverslips.  Data  was
collected from about 750 cells for each condition in each
experiment. Experiments were repeated at least three times
giving a total of at least 2,000 cells counted per condition. Data
are represented as mean±standard error.
Statistical analysis: Data are presented as the mean±SEM for
at  least  three  separate  experiments.  One  way  analysis  of
variance (ANOVA) was employed for statistical analysis with
significant differences determined as p<0.05.
RESULTS
Hypoxia  suppresses  TGFβ1-induced  myofibroblast
differentiation: We used periodic hypoxia (only 4 h/day),
which  we  know  induces  HIF1α  [3],  to  test  the  effect  of
hypoxia on rabbit keratocyte myofibroblast transformation.
Figure 1A shows that hypoxia treatment significantly reduced
the TGFβ1-induced myofibroblast phenotype from 4.8%±1%
to 1.2%±0.3% of the cell populations as determined from
immunocytochemistry. Hypoxia alone (no TGFβ) over three
days  did  not  increase  the  proportion  of  myofibroblasts
compared to the control (Figure 1A). To confirm that hypoxia
significantly  reduced  the  proportion  of  TGFβ1-induced
myofibroblasts,  we  repeated  the  experiment  using
quantitative flow cytometry analysis for α-SM actin. Figure
1B  shows  that  hypoxia  treatment  significantly  reduced
TGFβ1-induced  myofibroblast  differentiation  from  4.0%
±1.1% to 1.8%±0.4% 72 h after treatment. Overall, Figure 1
shows that hypoxia reduces TGFβ1-induced myofibroblast
transformation of corneal keratocytes and that hypoxia alone
does not induce the myofibroblast phenotype. These results
were confirmed at the protein level by western blotting. Figure
1C shows that TGFβ1 induces a significant amount of α-SM
actin expression while hypoxia suppresses TGFβ1-dependent
induction of α-SM actin expression.
Hypoxia does not reduce TGFβ1-induced pSmad3 level: To
explore  the  mechanism  by  which  hypoxia  suppresses
myofibroblast  transformation,  we  examined  the  effect  of
hypoxia  on  early  TGFβ-induced  signaling  events.  Smad
signaling  is  the  major  TGFβ-induced  signaling  pathway.
pSmad3 is needed for TGFβ-induced α-SM actin expression
in fibroblasts [14]. pSmad3 is a transcriptional factor that is
upregulated  within  4  h  of  TGFβ1  treatment  in  corneal
keratocytes  [15].  Therefore,  we  examined  the  effect  of
hypoxia  on  TGFβ1-induced  α-SM  actin  expression  and
Smad3 phosphorylation at 4 h.
Figure  2A  shows  that  TGFβ1  increases  α-SM  actin
expression  by  1.7±0.1  fold  after  only  4  h.  Interestingly,
hypoxia alone revealed a slight but not significant increase
(1.3±0.2 fold increase) in α-SM actin expression over the
control.  Hypoxia  significantly  reduced  the  α-SM  actin
expression induced by TGFβ1 at 4 h, which is consistent with
the  reduction  in  the  myofibroblast  phenotype  (Figure  1).
Figure 2B shows that TGFβ1 induced a significant increase
(3.75±1.25 fold increase) in pSmad3 4 h after treatment in
rabbit keratocytes compared to the control. Hypoxia by itself
slightly  increased  pSmad3,  but  this  increase  was  not
significant. The combination of hypoxia with TGFβ1 had no
effect on induced pSmad3 levels, indicating that inhibition of
TGFβ-induced  α-SM  actin  expression  by  hypoxia  is  not
through interference with pSmad3.
Hypoxia does not alter the level of interaction of CBP and
pSmad3 induced by TGFβ1: TGFβ1-induced Smad signaling
needs the binding of the coactivator, CBP/p300, to exert its
function. The transcription factor, HIF1α, which is induced
by hypoxia, also needs CBP as a coactivator. Concurrent
activation of Smads and Hif1α might lead to a competitive
inhibition  of  pSmad3-CBP  interaction.  We  tested  this
possibility by co-immunoprecipitation of CBP from nuclear
extracts 4 h after treatment and then probed for pSmad3.
Figure 3 shows that hypoxia or TGFβ1 alone induced a
significant increase in interaction between pSmad3 and CBP
(1.8±0.4 and 2.4±0.1 fold increase, respectively). However,
hypoxia+TGFβ1 (2.6±0.3 fold increase) did not significantly
change the TGFβ-induced pSmad3-CBP interaction. These
results  indicate  that  the  reduction  of  TGFβ-induced
myofibroblast  formation  and  α-SM  actin  expression  by
hypoxia is not through the reduction of pSmad3 or pSmad3-
CBP interaction.
TGFβ induced pERK is not altered by hypoxia: In addition to
increasing pSmad3 activation, TGFβ significantly increases
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1829phosphorylation of ERK at 4 h. Both TGFβ-induced αSM
actin  and  pERK  are  significantly  reduced  by  the  MEK
(mitogen-activated protein kinase kinase) inhibitor, U0126,
indicating  an  important  role  for  pERK  in  inducing
Figure 1. Hypoxia suppresses TGFβ-induced myofibroblast transformation. A: Primary cultured rabbit corneal keratocytes on coverslips were
treated with hypoxia for 4 h each day for 72 h with or without TGFβ1. After treatment, cells were stained for α-SM actin (green) and nuclei
(DAPI, blue). Microscope images are representatives of indicated groups (magnification: 200×). Five randomly selected fields were taken
from each coverslip. The experiment was repeated three times. The bar graph shows the percentage of α-SM actin positive cells over total cell
count in each group from immunofluorescence analysis. Error bars represent the standard error of the mean (n=3 experiments). The asterisk
indicates that the indicated groups were significantly different from TGFβ (p<0.05). B: Primary rabbit keratocytes on 100 mm Petri dishes
were treated the same as in (A), stained for α-SM actin and then analyzed by flow cytometry. Representative images show α-SM actin
fluorescence on the x-axis and forward scatter on the y-axis. Bar graph shows the percentage of α-SM actin positive cells over total cell count
in each group. The experiment was repeated three times. Error bars represent the standard error of the mean (n=3). The asterisk denotes that
the indicated groups were significantly different from TGFβ (p<0.05). C: Primary rabbit keratocytes on the Petri dish were treated the same
as in (A). Whole cell lysates were collected immediately after treatment and analyzed by western blot for α-SM actin. The image shown is
the representative western blot of three experiments.
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1830myofibroblasts  [15].  Figure  4  shows  that  hypoxia  alone
significantly reduced pERK below the control level in rabbit
keratocytes.  Interestingly,  hypoxia  did  not  reduce  TGFβ-
induced  ERK  phosphorylation.  Instead,  pERK  was
significantly increased relative to TGFβ alone. Figure 4 also
shows  that  there  was  no  change  in  total  ERK,  pJNK
(phosphorylated  jun  kinase),  or  phospho-p38  levels  in  all
experimental  groups  at  4  h  after  treatment.  These  results
indicate  that  hypoxia  inhibition  of  TGFβ1-induced  α-SM
actin  expression  in  rabbit  keratocytes  is  not  through
interference with ERK activation.
Hypoxia reduces TGFβ-induced active RhoA: TGFβ can also
activate the small GTP-binding protein, RhoA. The RhoA
pathway has a role in α-SM actin expression in rabbit corneal
myofibroblasts  [16].  Recently,  we  found  that  in  rabbit
keratocytes, TGFβ1 transiently induces GTP-RhoA between
5  and  15  min,  peaking  at  approximately  7  min,  and  that
interfering with RhoA activation by ROCK (Rho-associated
coil-containing protein kinase) inhibition reduced αSM actin
expression after 4 h of TGFβ exposure [15]. Here, we tested
the  effect  of  hypoxia  on  GTP-RhoA  following  7  min  of
TGFβ1  treatment.  Cells  were  pre-equilibrated  in  hypoxic
media for 4 h. TGFβ was added to the cells within the hypoxia
chamber, and cells harvested for western blot analysis 7 min
later. Figure 5 shows that TGFβ1 significantly increased the
GTP-RhoA  level  (1.38±0.15  fold  increase)  after  7  min
Figure  2.  Hypoxia  treatment  reduces
TGFβ1  induced  α-SM  actin  but  not
Smad3  phosphorylation.  Primary
isolated rabbit keratocytes were treated
with hypoxia together with or without
TGFβ1 for 4 h. Whole cell lysates were
collected  immediately  after  treatment
and analyzed by western blot for α-SM
actin  (A),  pSmad3  (B),  and
totalSmad2/3. Vimentin was used as a
loading control. Bar graphs show fold
increase of band intensity of each group
compared to vimentin (A) and to total
Smad2/3 (B). Error bars represent the
standard error of the mean (n=3). The
asterisk denotes p<0.05.
Figure  3.  Hypoxia  does  not  reduce
TGFβ1  induced  interaction  between
pSmads and CBP in rabbit keratocytes.
Nuclear extracts were collected 4 h after
corresponding  treatment  and
immunoprecipitated  with  anti-CBP
antibody.  Eluates  were  separated  by
SDS–PAGE  and  probed  for  pSmad3.
Blots were also probed for CBP as an
internal  control.  A:  Image  shows  a
representative  western  blot.  B:  Bar
graph  shows  the  relative  change  of
pSmad3 over the control group. Error
bars represent the standard error of the
mean (n=3). The asterisk denotes that
the indicated groups were significantly
different from control (p<0.05).
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1831compared to the control. Hypoxia alone did not significantly
change GTP-RhoA. However, TGFβ+hypoxia significantly
reduced the GTP-RhoA level to less than the control level.
DISCUSSION
In this study, we report for the first time that hypoxia reduces
TGFβ1-induced  myofibroblast  transformation  in  primary
isolated  rabbit  keratocytes.  Our  results  demonstrate  that
hypoxia  inhibits  TGFβ1-induced  keratocyte  from
myofibroblast transformation (Figure 1) and also reduces α-
SM actin expression at 4 h (Figure 2A) and 72 h (Figure 1B)
after TGFβ1 treatment.
Hypoxia as an individual stress factor can induce α-SM
actin  expression  in  fetal  cardiac  fibroblasts  [17].  This
appeared to happen with rabbit keratocytes (Figure 2A), but
this induction was not significant. On the other hand, hypoxia
did not induce α-SM actin-containing filaments at 72 h (Figure
1A,C). This may be due to the lower α-SM actin level induced
by hypoxia relative to TGFβ and the altered expression of
associated cytoskeletal proteins needed for the alignment of
stress fibers [18].
To examine the possible mechanism of hypoxia’s effect
on myofibroblast transformation, we explored early events in
the signaling pathways induced by TGFβ. Smads are the major
effectors  of  TGFβ  signaling.  pSmad3  recruits  the
transcriptional  coactivator,  CBP/p300,  for  DNA  binding
[19]. Recent studies showed that one mechanism of inhibition
of TGFβ-induced myofibroblast transformation and collagen
synthesis  is  by  increased  competition  for  CBP/P300  with
Smad  signaling  [12].  Figure  2  showed  that  pSmad3  is
activated by TGFβ within 4 h, and α-SM actin expression is
significantly  increased.  This  increase  in  α-SM  actin  is
suppressed by concomitant hypoxia. We found that hypoxia
treatment alone may induce Smad signaling by increasing the
interaction of pSmad3 with CBP in rabbit keratocytes (Figure
3),  but  this  induction  was  not  statistically  significant.
However, hypoxia and TGFβ together did not reduce the level
of pSmad3 (Figure 2) or pSmad3/CBP interaction relative to
TGFβ  alone  (Figure  3).  Overall,  modulation  of  Smad
signaling is not likely to be involved in the hypoxia inhibition
of myofibroblast transformation.
We  showed  that  TGFβ  upregulates  pERK  in  rabbit
keratocytes, which is consistent with previous findings in lung
fibroblasts  where  pERK  upregulation  contributes  to
myofibroblast  formation  [20].  The  reduction  of  ERK
phosphorylation has been shown to be one mechanism that
interferes with TGFβ signaling in cardiac fibroblasts [12].
Furthermore,  inhibition  of  ERK  phosphorylation  in
Figure 4. Hypoxia inhibition of TGFβ1-
induced α-SM actin is independent of
MAPK activation. A: Whole cell lysates
were collected 4 h after treatment and
assayed by western blot for pERK, total
ERK,  pJNK,  and  phospho-p38  as
indicated.  Vimentin  was  used  as  a
loading control. B: The bar graph shows
the relative increase of pERK in each
group  over  the  control.  Error  bars
represent  standard  error  of  the  mean
(n=3).  The  asterisk  indicates  that  the
indicated  groups  were  significantly
different from control (p<0.05).
Figure 5. RhoA activation is involved in
hypoxia inhibition. Cells were treated
under  normoxia  (control)  or  hypoxia
(H) with or without 5 ng/ml TGFβ1 for
7 min. GTP bound RhoA was pulled
down and assayed by western blot with
anti-RhoA antibody. Total RhoA from
whole cell lysates was detected as the
relative  control.  The  representative
image  of  three  experiments  is  shown
here. Error bars represent standard error
of the mean (n=3). The asterisk denotes
that  the  indicated  groups  were
significantly  different  from  TGFβ1
(p<0.05).
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1832keratocytes significantly reduced TGFβ-induced α-SM actin
expression [15]. Here, we found that hypoxia treatment alone
decreases  pERK  significantly  in  rabbit  keratocytes.  This
regulation of pERK by hypoxia is cell type specific since
hypoxia has been shown to be a strong inducer for ERK
phosphorylation in other cell types [21]. Interestingly, our
experiments showed that even though hypoxia alone reduces
pERK,  it  significantly  increases  ERK  phosphorylation
induced  by  TGFβ1  (Figure  4).  To  our  knowledge,  this
paradoxical effect on ERK phosphorylation by hypoxia with/
without TGFβ has not been reported. This result could be
consistent with induction of dissimilar signaling components
by hypoxia and TGFβ1, which together lead to an enhanced
ERK phosphorylation. Whatever the mechanism of this effect
on  pERK,  the  hypoxia  inhibition  of  myofibroblast
differentiation is not through reduction of pERK.
RhoA activation is involved in TGFβ1-induced α-SM
actin  expression  in  several  cell  types  including  corneal
fibroblasts  and  keratocytes  [13,22,23].  In  corneal
myofibroblasts,  TGFβ1-induced  α-SM  actin  expression
involves  RhoA/ROCK  and  RhoA/mDia1  pathways  and  is
suppressed by a ROCK inhibitor [16]. Recently, we found that
in rabbit keratocytes, TGFβ1 transiently induces GTP-RhoA
between 5 and 15 min, peaking at approximately 7 min and
that interfering with RhoA activation by ROCK inhibition
reduced α-SM actin expression after 4 h of TGFβ exposure
[15]. Hypoxia has been shown to activate RhoA signaling in
pulmonary arterial smooth muscle cells and A549 cells [24,
25]. In rabbit keratocytes, we did not find a significant change
in  RhoA  activation  by  hypoxia.  But  in  the  presence  of
hypoxia, the initial TGFβ1-induced activation of RhoA in
corneal  keratocytes  was  significantly  reduced  (Figure  5),
suggesting  that  the  RhoA  pathway  might  be  involved  in
hypoxia inhibition of TGFβ1-induced α-SM actin. Further
studies  are  needed  to  test  the  hypothesis  that  RhoA  is
responsible  for  the  hypoxia-dependent  inhibition  of
myofibroblast formation.
In  summary,  hypoxia  reduces  TGFβ1-induced
myofibroblast transformation in rabbit keratocytes in vitro.
Hypoxia does not interfere with TGFβ-induced changes in
pSmad3,  CBP  interaction,  or  pERK.  However,  hypoxia
reduces RhoA activation induced by TGFβ. Hypoxia alone
induces  α-SM  actin  expression,  consistent  with  enhanced
Smad  signaling,  but  does  not  induce  the  myofibroblast
phenotype. In vivo, corneal hypoxia alone, for example that
produced by wearing contact lenses, also does not induce the
myofibroblast  phenotype.  This  suggests  that  intermittent
hypoxia, for example that achieved by contact lens wear,
could be investigated as a possible tool to reduce fibrosis
following corneal wounding or surgery.
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